AXON PARTNERS GRP EO -10 Total Liabilities
AXON PARTNERS GRP EO -10 total liabilities. Based on the latest financial reports, AXON PARTNERS GRP EO -10 (XE1) has total liabilities worth €8.31 Million EUR (≈ $9.72 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XE1 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of AXON PARTNERS GRP EO -10 (2021–2024)
Total liabilities of AXON PARTNERS GRP EO -10 from 2021 to 2024. This chart illustrates how AXON PARTNERS GRP EO -10's total liabilities have evolved over time, based on quarterly financial data.
AXON PARTNERS GRP EO -10 Competitors by Total Liabilities
The table below lists competitors of AXON PARTNERS GRP EO -10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Veracruz Properties SOCIMI SA
MC:YVCP
|
Spain | €41.37 Million |
|
U-Best Polymer Industry Co Ltd
TWO:4714
|
Taiwan | NT$3.82 Billion |
|
Terns Pharmaceuticals Inc
NASDAQ:TERN
|
USA | $17.59 Million |
|
Pylon Public Company Limited
BK:PYLON
|
Thailand | ฿467.28 Million |
|
OncoQuest Pharmaceuticals Inc
KQ:078590
|
Korea | ₩19.38 Billion |
|
Shotspotter Inc
NASDAQ:SSTI
|
USA | $63.58 Million |
|
Likhitha Infrastructure Limited
NSE:LIKHITHA
|
India | Rs512.61 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down AXON PARTNERS GRP EO -10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is AXON PARTNERS GRP EO -10's balance sheet.
Liquidity & Leverage Metrics
AXON PARTNERS GRP EO -10 Total Liabilities Ratios Explained
AXON PARTNERS GRP EO -10 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how AXON PARTNERS GRP EO -10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for AXON PARTNERS GRP EO -10 (2021–2024)
The table below shows the annual total liabilities of AXON PARTNERS GRP EO -10 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.70 Million ≈ $7.83 Million |
-6.65% |
| 2023-12-31 | €7.18 Million ≈ $8.39 Million |
+39.79% |
| 2022-12-31 | €5.14 Million ≈ $6.00 Million |
-31.53% |
| 2021-12-31 | €7.50 Million ≈ $8.77 Million |
-- |
About AXON PARTNERS GRP EO -10
Axon Partners Group, S.A. is a private equity and venture capital firm specializing in all stages from seed to growth capital, growth equity, startups, lower middle market, early stage, pre-IPO, IPO, post IPO, expansion, mid venture, late venture sustainability, debt instrument, private debt and fund of funds investment. Within fund of funds, the firm seeks to invest in all sectors and stages fro… Read more